We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current SABS market cap is 19.75M. The company's latest EPS is USD -4.5718 and P/E is -0.48.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 1.27M | 305k | 945k | 263k | 0 |
| Operating Income | -5.32M | -18.87M | -11.39M | -10.2M | -11.31M |
| Net Income | -5.1M | -22.86M | -5.03M | -7.34M | -10.35M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 60.88M | 23.9M | 2.24M |
| Operating Income | -9k | -13.39M | -28.92M | -38.08M |
| Net Income | -9k | -17.15M | -18.74M | -42.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 28.34M | 83.94M | 71.37M | 61.89M | 53.8M |
| Total Liabilities | 13.08M | 26.64M | 18.55M | 15.77M | 16.89M |
| Total Equity | 15.26M | 57.3M | 52.82M | 46.12M | 36.9M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 322k | 79.37M | 50.91M | 83.94M |
| Total Liabilities | 306k | 40.82M | 19.85M | 26.64M |
| Total Equity | 16k | 38.55M | 31.06M | 57.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -11.67M | -25.12M | -10.75M | -18.47M | -24.76M |
| Investing | -85k | -153k | -31.36M | -20.14M | -21.29M |
| Financing | -864k | 66.77M | -394k | -715k | -1.39M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10k | 3.76M | -23.46M | -25.12M |
| Investing | N/A | -10.94M | -2.09M | -153k |
| Financing | 95k | 34.12M | 1.05M | 66.77M |
| Market Cap | 19.75M |
| Price to Earnings Ratio | -0.48 |
| Price to Sales Ratio | 8.99 |
| Price to Cash Ratio | 0.36 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 9.23M |
| Average Volume (1 week) | 566.72k |
| Average Volume (1 Month) | 205.09k |
| 52 Week Change | -63.97% |
| 52 Week High | 6.30 |
| 52 Week Low | 2.00 |
| Spread (Intraday) | 0.16 (7.21%) |
| Company Name | SAB Biotherapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sab.bio |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
